Pain News and Research

Latest Pain News and Research

New research reveals how good sleep can help chronic pain sufferers

Chronic pain sufferers could be kept physically active by improving the quality of their sleep, new research suggests.

28 Mar 2014

CDC identifies six new cases of people with Heartland virus

The Centers for Disease Control and Prevention in collaboration with health officials in Missouri and Tennessee have identified six new cases of people sick with Heartland virus: five in Missouri and one in Tennessee. The new cases, discovered in 2012 and 2013, are described today in CDC's Morbidity and Mortality Weekly Report.

28 Mar 2014

Study links broken heart syndrome to natural disasters

Dramatic spikes in cases of Takotsubo cardiomyopathy, also called broken heart syndrome, were found in two states after major natural disasters, suggesting the stress of disasters as a likely trigger, according to research to be presented at the American College of Cardiology's 63rd Annual Scientific Session.

28 Mar 2014

AMS' revenues decrease 4.6% to $3,937,000 in fourth quarter 2013

American Shared Hospital Services, a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, today announced financial results for the fourth quarter and 2013.

27 Mar 2014

Cardiovascular disease related deaths drop after implementation of public smoking ban

A new study on the impact of Michigan's statewide smoking ban adds to mounting evidence that policies prohibiting tobacco smoking in workplaces and other public spaces may substantially improve public health by reducing heart disease and death, according to research to be presented at the American College of Cardiology's 63rd Annual Scientific Session.

27 Mar 2014

New drug multiplies analgesic effect of opioids without increasing constipation

Scientists from the University of Granada have taken part, alongside the Esteve laboratory, in the development of a new drug that multiplies the analgesic effect of opioids (drugs for treating intense pain), without increasing constipation, one of the most common side-effects of these drugs, among which is morphine.

27 Mar 2014

CT scans allow rheumatologists to diagnose gout

Gout is on the rise among U.S. men and women, and this piercingly painful and most common form of inflammatory arthritis is turning out to be more complicated than had been thought.

27 Mar 2014

Biodelivery Sciences collaborates with Quintiles to launch BUNAVAIL in the U.S.

BioDelivery Sciences International, Inc. announced that it has entered into an agreement with Quintiles to provide a range of services to support the anticipated launch of BUNAVAIL (buprenorphine and naloxone buccal film), BDSI's proposed maintenance treatment for opioid dependence.

27 Mar 2014

People urged to undergo oral cancer screenings as part of Oral Cancer Awareness Month

Oral and oropharyngeal cancer (cancer of the mouth and upper throat) collectively kill nearly one person every hour of every day of the year.

27 Mar 2014

Research points strong reason to develop new class of antidepressant drug

Scientists have shown for the first time that a chemical in the brain called galanin is involved in the risk of developing depression.

From The University of Manchester 27 Mar 2014

State highlights: Bad grades for 45 states on medical price posting; Kan. Planned Parenthood funds; Conn. for-profit hospitals

A selection of health policy stories from California, Kansas, Connecticut, North Carolina and Minnesota.

27 Mar 2014

BD Micro-Fine Ultra Pen Needle with Pentapoint technology launched in the UK and Ireland

BD (Becton, Dickinson and Company), a leading global medical technology company, announced today the launch in the UK and Ireland of BD Micro-Fine Ultra with 5-bevel needle technology, clinically demonstrated to improve injection comfort for diabetes patients, and enhancing the injection advantages of the current BD Micro-Fine+ Pen Needle.

From BD (Becton, Dickinson and Company) 27 Mar 2014

Dr. Reddy's Laboratories launches Amlodipine Besylate and Atorvastatin Calcium Tablets

Dr. Reddy's Laboratories announced today that it has launched Amlodipine Besylate and Atorvastatin Calcium Tablets 2.5/10mg, 2.5/20mg, 2.5/40mg, 5/10mg, 5/20mg, 5/40mg, 5/80mg, 10/10mg, 10/20mg, 10/40mg and 10/80 mg a therapeutic equivalent generic version of CADUET (amlodipine Besylate and atorvastatin calcium) tablets, in the US market on March 26, 2014, following the approval by the United States Food & Drug Administration.

27 Mar 2014

Study highlights importance of stress management, healthy lifestyle habits for people with migraine

Migraine sufferers who experienced reduced stress from one day to the next are at significantly increased risk of migraine onset on the subsequent day, according to a new study conducted by researchers at the Montefiore Headache Center and Albert Einstein College of Medicine at Yeshiva University.

27 Mar 2014

Egalet provides business update, reports full year 2013 financial results

Egalet Corporation ("Egalet") today reported business highlights and financial results for the year ended December 31, 2013. This marks the first time that Egalet is reporting its operating results as a public company.

26 Mar 2014

Ulcerative colitis control: an interview with Dr Paul Robinson, Medical Director, MSD UK

Ulcerative colitis (UC) is an inflammatory bowel disease (IBD), which means there is chronic inflammation and ulceration in the lining of the digestive tract, usually in the large intestine.

26 Mar 2014

Roundup: Calif. malpractice cap ballot measure; Colo. immunizations bill; Fla. cash-only clinic loophole

A selection of health policy stories from California, Colorado, Florida, Arizona, Virginia, Maryland and Massachusetts.

26 Mar 2014

United Therapeutics' Remodulin Injection gets approval in Japan for PAH treatment

United Therapeutics Corporation today announced that Japan's Ministry of Health, Labour and Welfare has granted approval for Remodulin (treprostinil) Injection for the treatment of pulmonary arterial hypertension (PAH) by subcutaneous and intravenous administration.

26 Mar 2014

Xenon collaborates with Genentech to develop new therapeutic targets for treating pain

Xenon Pharmaceuticals Inc. today announced the establishment of a new collaboration with Genentech, a member of the Roche Group, for pain genetics, with the goal of discovering and validating new therapeutic targets and mechanisms for treating pain.

26 Mar 2014

Axonics Modulation Technologies completes $32.6 million Series A preferred stock financing

Axonics Modulation Technologies, Inc., a developer of novel implantable neuromodulation technology, announced today that it has completed a $32.6 million Series A preferred stock financing.

25 Mar 2014

Pain News and Research

Latest Pain News and Research

New research reveals how good sleep can help chronic pain sufferers

CDC identifies six new cases of people with Heartland virus

Study links broken heart syndrome to natural disasters

AMS' revenues decrease 4.6% to $3,937,000 in fourth quarter 2013

Cardiovascular disease related deaths drop after implementation of public smoking ban

New drug multiplies analgesic effect of opioids without increasing constipation

CT scans allow rheumatologists to diagnose gout

Biodelivery Sciences collaborates with Quintiles to launch BUNAVAIL in the U.S.

People urged to undergo oral cancer screenings as part of Oral Cancer Awareness Month

Research points strong reason to develop new class of antidepressant drug

State highlights: Bad grades for 45 states on medical price posting; Kan. Planned Parenthood funds; Conn. for-profit hospitals

BD Micro-Fine Ultra Pen Needle with Pentapoint technology launched in the UK and Ireland

Dr. Reddy's Laboratories launches Amlodipine Besylate and Atorvastatin Calcium Tablets

Study highlights importance of stress management, healthy lifestyle habits for people with migraine

Egalet provides business update, reports full year 2013 financial results

Ulcerative colitis control: an interview with Dr Paul Robinson, Medical Director, MSD UK

Roundup: Calif. malpractice cap ballot measure; Colo. immunizations bill; Fla. cash-only clinic loophole

United Therapeutics' Remodulin Injection gets approval in Japan for PAH treatment

Xenon collaborates with Genentech to develop new therapeutic targets for treating pain

Axonics Modulation Technologies completes $32.6 million Series A preferred stock financing

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Pain News and Research

Latest Pain News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in